l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | TMAO as a
Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Trimethylamine N Oxide in Relation to Cardiometabolic HealthCause or Effect? Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Trimethylamine Noxide: breathe new life Subramaniam 2018 British Journal of Pharmacology Wiley Online Library Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





